1. Home
  2. CLDI vs PRSO Comparison

CLDI vs PRSO Comparison

Compare CLDI & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

N/A

Current Price

$1.15

Market Cap

9.2M

Sector

Health Care

ML Signal

N/A

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.98

Market Cap

8.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDI
PRSO
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
8.4M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
CLDI
PRSO
Price
$1.15
$0.98
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
69.6K
311.8K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,001,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$35.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.15
52 Week Low
$1.10
$0.52
52 Week High
$19.20
$2.37

Technical Indicators

Market Signals
Indicator
CLDI
PRSO
Relative Strength Index (RSI) 36.27 50.94
Support Level $1.12 $0.91
Resistance Level $1.23 $1.00
Average True Range (ATR) 0.07 0.06
MACD -0.01 0.01
Stochastic Oscillator 10.52 62.00

Price Performance

Historical Comparison
CLDI
PRSO

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

Share on Social Networks: